1. Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population
   Katarzyna Michalska et al, 2023, Molecular Biology Reports CrossRef
2. SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
   Stephanie Koller et al, 2022, Frontiers in Pharmacology CrossRef
3. SLCO4A1-AS1 Facilitates the Malignant Phenotype via miR-149-5p/STAT3 Axis in Gastric Cancer Cells
   Qing Li et al, 2021, Journal of Oncology CrossRef
4. Enzyme/pH Dual-Responsive Size-Shrinkable Nanocomposites for Tumor Penetration and Enhanced Multimodal Cancer Therapy
   Hui Wang et al, 2023, ACS Applied Nano Materials CrossRef